Literature DB >> 9846793

Additional clinical and microbiological effects of amoxicillin and metronidazole after initial periodontal therapy.

E G Winkel1, A J van Winkelhoff, U van der Velden.   

Abstract

The aims of this study were to evaluate the clinical and microbiological effects of initial periodontal therapy (IT) and to determine the additional effects of systemic amoxicillin (Flemoxin Solutab) 375 mg TID plus metronidazole 250 mg TID therapy, in patients with adult Actinobacillus actinomycetemcomitans (Aa)-associated periodontitis in conjunction with either Porphyromonas gingivalis (Pg), Bacteroides forsythus (Bf) and/or Prevotella intermedia (Pi). In addition the adverse effects of the antimicrobial therapy were also documented. A total of 22 patients were enrolled. The deepest, bleeding pocket in each quadrant was selected and at these 4 experimental sites clinical measurements and microbiological testing was carried out at baseline, after (IT), i.e., 21 weeks after baseline, and after antimicrobial therapy (AM), i.e., 35 weeks after baseline. At baseline, the mean plaque index (PI) amounted 0.5, 0.1 after IT and 0.3 after systemic AM. The mean bleeding index decreased from 1.6 to 1.2 after IT and a further decrease to 0.7 after AM was noted. Suppuration was completely eliminated after AM. The mean change of probing pocket depth (PPD) after IT amounted 1.4 mm and was further reduced with an additional mean change of 1.1 mm after medication. Clinical attachment gain was 1.1 mm after IT and an additional 0.9 mm was observed after AM. One of the 22 Aa positive patients and 4 of 17 Pg positive patients became negative for these species after IT. The number of patients with detectable Pi decreased from 16 to 10 after IT. After AM, in comparison to baseline, suppression below detection level for Aa was achieved in 19 out of 22, for Pg in 9 out of 17, for Bf in 13 out of 14, and for Pi in 11 out of 16 patients. By contrast, higher frequencies of Peptostreptococcus micros and Fusobacterium nucleatum were found after AM. On the basis of the microbiological results the study group was separated into 2 subgroups: group A consisted of subjects who had no detectable levels of Aa, Pg, Bf and <5% of Pi after AM. Group B consisted of those who still showed presence of one of these 3 species and/or > or =5% levels of Pi. After AM, group B had significantly higher PI, BI, PPD and CAL scores then group A. It is concluded that group A showed low plaque scores and no detectable periodontal pathogens. This microbiological condition has been associated with a long-term stable periodontium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846793     DOI: 10.1111/j.1600-051x.1998.tb02382.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  7 in total

1.  Benefits of early systemic antibiotics in localized aggressive periodontitis: a retrospective study.

Authors:  Dennis Beliveau; Ingvar Magnusson; John A Bidwell; Edward F Zapert; Ikramuddin Aukhil; Shannon M Wallet; Luciana M Shaddox
Journal:  J Clin Periodontol       Date:  2012-08-29       Impact factor: 8.728

2.  Long-term clinical response to treatment and maintenance of localized aggressive periodontitis: a cohort study.

Authors:  Karina A F S Miller; Luciana S Branco-de-Almeida; Sandra Wolf; Nicole Hovencamp; Tina Treloar; Peter Harrison; Ikramuddin Aukhil; Yan Gong; Luciana M Shaddox
Journal:  J Clin Periodontol       Date:  2016-12-27       Impact factor: 8.728

3.  Persistence of extracrevicular bacterial reservoirs after treatment of aggressive periodontitis.

Authors:  Jason D Johnson; Ruoqiong Chen; Patricia A Lenton; Guizhen Zhang; James E Hinrichs; Joel D Rudney
Journal:  J Periodontol       Date:  2008-12       Impact factor: 6.993

4.  Clinical case report on treatment of generalized aggressive periodontitis.

Authors:  Mi-Hwa Jung; Jin-Woo Park; Jo-Young Suh; Jae-Mok Lee
Journal:  J Periodontal Implant Sci       Date:  2010-10-31       Impact factor: 2.614

5.  Effects of Implant Surface Debridement and Systemic Antibiotics on the Clinical and Microbiological Variables of Periimplantitis.

Authors:  Muhammad Irshad; Mohammad Khursheed Alam; Sajid Ali; Ahmad Alawneh; Mohammed Alhadi; Ahmed Alhadi; Ahmed Ali Alfawzan
Journal:  Biomed Res Int       Date:  2021-01-22       Impact factor: 3.411

6.  Clinical, microbiological, and immunological effects of systemic probiotics in periodontal treatment: study protocol for a randomized controlled trial.

Authors:  Belen Retamal-Valdes; Wim Teughels; Laryssa Macedo Oliveira; Rebeca Nascimento da Silva; Aretuza Fritoli; Patricia Gomes; Geisla Mary Silva Soares; Natalie Temporão; Camila Pinheiro Furquim; Poliana Mendes Duarte; Helio Doyle; Marcelo Faveri; Luciene Cristina Figueiredo; Magda Feres
Journal:  Trials       Date:  2021-04-15       Impact factor: 2.279

7.  Treating chronic periodontitis: current status, challenges, and future directions.

Authors:  Luciana M Shaddox; Clay B Walker
Journal:  Clin Cosmet Investig Dent       Date:  2010-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.